• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BAG3 依赖性表达 Mcl-1 使突变型 KRAS 结肠癌细胞对 HSP90 抑制剂 AUY922 产生耐药性。

BAG3-dependent expression of Mcl-1 confers resistance of mutant KRAS colon cancer cells to the HSP90 inhibitor AUY922.

机构信息

School of Biomedical Sciences and Pharmacy, The University of Newcastle, New South Wales, Australia.

School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia.

出版信息

Mol Carcinog. 2018 Feb;57(2):284-294. doi: 10.1002/mc.22755. Epub 2017 Nov 14.

DOI:10.1002/mc.22755
PMID:29068469
Abstract

Past studies have shown that mutant KRAS colon cancer cells are susceptible to apoptosis induced by the HSP90 inhibitor AUY922. Nevertheless, intrinsic and acquired resistance remains an obstacle for the potential application of the inhibitor in the treatment of the disease. Here we report that Mcl-1 is important for survival of colon cancer cells in the presence of AUY922. Mcl-1 was upregulated in mutant KRAS colon cancer cells selected for resistance to AUY922-induced apoptosis. This was due to its increased stability mediated by Bcl-2-associated athanogene domain 3 (BAG3), which was also increased in resistant colon cancer cells by heat shock factor 1 (HSF1) as a result of chronic endoplasmic reticulum (ER) stress. Functional investigations demonstrated that inhibition of Mcl-1, BAG3, or HSF1 triggered apoptosis in resistant colon cancer cells, and rendered AUY922-naïve colon cancer cells more sensitive to the inhibitor. Together, these results identify that the HSF1-BAG3-Mcl-1 signal axis is critical for protection of mutant KRAS colon cancer cells from AUY922-induced apoptosis, with potential implications for targeting HSF1/BAG3/Mcl-1 to improve the efficacy of AUY922 in the treatment of colon cancer.

摘要

过去的研究表明,突变型 KRAS 结肠癌细胞容易被 HSP90 抑制剂 AUY922 诱导凋亡。然而,内在和获得性耐药仍然是该抑制剂在疾病治疗中应用的障碍。在这里,我们报告 Mcl-1 对于 AUY922 存在时结肠癌细胞的存活很重要。在对 AUY922 诱导的凋亡具有耐药性的突变型 KRAS 结肠癌细胞中,Mcl-1 上调。这是由于其稳定性增加,这是由 Bcl-2 相关的 Athanogene 结构域 3(BAG3)介导的,BAG3 在耐药性结肠癌细胞中也由于慢性内质网(ER)应激而由热休克因子 1(HSF1)增加。功能研究表明,抑制 Mcl-1、BAG3 或 HSF1 可在耐药性结肠癌细胞中引发凋亡,并使 AUY922 敏感的结肠癌细胞对抑制剂更敏感。总之,这些结果表明 HSF1-BAG3-Mcl-1 信号轴对于保护突变型 KRAS 结肠癌细胞免受 AUY922 诱导的凋亡至关重要,这可能暗示靶向 HSF1/BAG3/Mcl-1 以提高 AUY922 治疗结肠癌的疗效。

相似文献

1
BAG3-dependent expression of Mcl-1 confers resistance of mutant KRAS colon cancer cells to the HSP90 inhibitor AUY922.BAG3 依赖性表达 Mcl-1 使突变型 KRAS 结肠癌细胞对 HSP90 抑制剂 AUY922 产生耐药性。
Mol Carcinog. 2018 Feb;57(2):284-294. doi: 10.1002/mc.22755. Epub 2017 Nov 14.
2
Inhibition of HSP90 by AUY922 Preferentially Kills Mutant KRAS Colon Cancer Cells by Activating Bim through ER Stress.AUY922对热休克蛋白90的抑制作用通过内质网应激激活Bim,优先杀死突变型KRAS结肠癌细胞。
Mol Cancer Ther. 2016 Mar;15(3):448-59. doi: 10.1158/1535-7163.MCT-15-0778. Epub 2016 Feb 1.
3
Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922.ERK和Akt的重新激活赋予了突变型BRAF结肠癌细胞对HSP90抑制剂AUY922的抗性。
Oncotarget. 2016 Aug 2;7(31):49597-49610. doi: 10.18632/oncotarget.10414.
4
HSP90 inhibitor NVP-AUY922 enhances TRAIL-induced apoptosis by suppressing the JAK2-STAT3-Mcl-1 signal transduction pathway in colorectal cancer cells.热休克蛋白90抑制剂NVP-AUY922通过抑制结肠癌细胞中的JAK2-STAT3-Mcl-1信号转导途径增强肿瘤坏死因子相关凋亡诱导配体诱导的细胞凋亡。
Cell Signal. 2015 Feb;27(2):293-305. doi: 10.1016/j.cellsig.2014.11.013. Epub 2014 Nov 18.
5
The natural compound cantharidin induces cancer cell death through inhibition of heat shock protein 70 (HSP70) and Bcl-2-associated athanogene domain 3 (BAG3) expression by blocking heat shock factor 1 (HSF1) binding to promoters.天然化合物斑蝥素通过抑制热休克因子 1(HSF1)与启动子结合,抑制热休克蛋白 70(HSP70)和 Bcl-2 相关抗凋亡基因 3(BAG3)的表达,诱导癌细胞死亡。
J Biol Chem. 2013 Oct 4;288(40):28713-26. doi: 10.1074/jbc.M113.488346. Epub 2013 Aug 27.
6
The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer.HSP90 抑制剂 NVP-AUY922 可减弱 KRAS 突变型非小细胞肺癌对内在 PI3K 抑制剂的耐药性。
Cancer Lett. 2017 Oct 10;406:47-53. doi: 10.1016/j.canlet.2017.07.028. Epub 2017 Aug 7.
7
The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib.热休克蛋白90(HSP90)抑制剂NVP - AUY922可使对MEK抑制剂曲美替尼具有内在抗性的KRAS突变型非小细胞肺癌变得敏感。
Cancer Lett. 2016 Mar 1;372(1):75-81. doi: 10.1016/j.canlet.2015.12.015. Epub 2015 Dec 23.
8
The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-κB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells.热休克蛋白90抑制剂NVP-AUY922-AG可抑制核因子κB信号传导,克服微环境细胞保护作用,并且在原发性慢性淋巴细胞白血病细胞中与氟达拉滨具有高度协同作用。
Oncotarget. 2012 May;3(5):525-34. doi: 10.18632/oncotarget.491.
9
Interference with the HSF1/HSP70/BAG3 Pathway Primes Glioma Cells to Matrix Detachment and BH3 Mimetic-Induced Apoptosis.干扰HSF1/HSP70/BAG3信号通路可使胶质瘤细胞对基质脱离和BH3模拟物诱导的凋亡敏感。
Mol Cancer Ther. 2017 Jan;16(1):156-168. doi: 10.1158/1535-7163.MCT-16-0262. Epub 2016 Oct 24.
10
HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2.HSP90 抑制剂(NVP-AUY922)增强了表达 BCL-2 的小细胞肺癌中 BCL-2 抑制剂(ABT-737)的抗癌作用。
Cancer Lett. 2017 Dec 28;411:19-26. doi: 10.1016/j.canlet.2017.09.040. Epub 2017 Oct 4.

引用本文的文献

1
HSP90β Impedes STUB1-Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma.HSP90β 抑制 STUB1 诱导的 YTHDF2 泛素化以驱动肝癌对索拉非尼的耐药性。
Adv Sci (Weinh). 2023 Sep;10(27):e2302025. doi: 10.1002/advs.202302025. Epub 2023 Jul 28.
2
AR12 increases BAG3 expression which is essential for Tau and APP degradation via LC3-associated phagocytosis and macroautophagy.AR12 通过 LC3 相关的吞噬作用和巨自噬增加 BAG3 的表达,这对于 Tau 和 APP 的降解是必不可少的。
Aging (Albany NY). 2022 Oct 13;14(20):8221-8242. doi: 10.18632/aging.204337.
3
Endoplasmic Reticulum Stress of Gut Enterocyte and Intestinal Diseases.
肠道肠上皮细胞内质网应激与肠道疾病
Front Mol Biosci. 2022 Mar 24;9:817392. doi: 10.3389/fmolb.2022.817392. eCollection 2022.
4
AUY922 induces retinal toxicity through attenuating TRPM1.AUY922 通过抑制 TRPM1 诱导视网膜毒性。
J Biomed Sci. 2021 Jul 23;28(1):55. doi: 10.1186/s12929-021-00751-5.
5
The role of BAG3 in health and disease: A "Magic BAG of Tricks".BAG3 在健康和疾病中的作用:一个“万能的魔术袋”。
J Cell Biochem. 2022 Jan;123(1):4-21. doi: 10.1002/jcb.29952. Epub 2021 May 14.
6
The Road of Solid Tumor Survival: From Drug-Induced Endoplasmic Reticulum Stress to Drug Resistance.实体瘤生存之路:从药物诱导的内质网应激到耐药性
Front Mol Biosci. 2021 Apr 13;8:620514. doi: 10.3389/fmolb.2021.620514. eCollection 2021.
7
Knockdown of Bcl-2-Associated Athanogene-3 Can Enhance the Efficacy of BGJ398 via Suppressing Migration and Inducing Apoptosis in Gastric Cancer.敲低 Bcl-2 相关泛素样蛋白 3 能够通过抑制迁移和诱导凋亡增强 BGC-823 对胃癌的疗效。
Dig Dis Sci. 2021 Sep;66(9):3036-3044. doi: 10.1007/s10620-020-06640-5. Epub 2020 Oct 22.